CDC WORLD TRADE CENTER (WTC) HEALTH PROGRAM PHARMACY BENEFITS MANAGER
ID: 75D301-254-SS-524292Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)

PSC

MEDICAL- PHARMACOLOGY (Q517)

Original Source

https://sam.gov/opp/1086496deb8d4b47853d25489e272781/view
Timeline
  1. 1
    Posted Jan 15, 2025, 12:00 AM UTC
  2. 2
    Updated Jan 28, 2025, 12:00 AM UTC
  3. 3
    Due Feb 14, 2025, 10:00 PM UTC
Description

The Centers for Disease Control and Prevention (CDC) is seeking qualified vendors to provide Pharmacy Benefits Manager (PBM) services for the World Trade Center (WTC) Health Program, which supports responders and survivors affected by the 9/11 attacks. The contract will span three years, including a 12-month implementation period, a peak operational phase, and a 12-month transition-out period, requiring vendors to demonstrate capabilities in system customization, customer care, clinical services, reporting, and cost control. This initiative is critical for ensuring compliance with the program's regulations, which mandate customized drug formularies and prior authorization processes for medically necessary treatments. Interested parties must submit their qualifications by February 14, 2025, and can direct inquiries to Laurie Presley at xnp0@cdc.gov.

Point(s) of Contact
Laurie Presley
xnp0@cdc.gov
Files
Title
Posted
1.DRAFT SOW_PBM_3Year.pdf
Jan 15, 2025, 8:12 PM UTC
The World Trade Center (WTC) Health Program was created by the Zadroga Act to offer healthcare services to responders and survivors of the 9/11 attacks. The program provides medical monitoring and treatment for conditions linked to the attacks, with enrollment numbers showing a recent increase in both responders and survivors. The program presents unique challenges in managing pharmacy benefits due to its limited coverage scope, which only includes specified conditions. A prescription benefit manager (PBM) is needed to deliver comprehensive pharmacy services while ensuring compliance with federal regulations, including a need for customized technology to manage formularies and prior authorizations effectively. Key tasks for the PBM include developing a functioning pharmacy network across the US, implementing electronic systems for efficient claims processing, conducting regular audits, and establishing a quality assurance plan. The PBM must also provide transparent pricing, manage change controls, and implement an effective communications strategy to keep stakeholders informed. This contract encompasses all aspects of pharmacy benefit operations for the WTC Health Program, aimed at ensuring optimal care for enrollees while maintaining regulatory compliance and cost-effectiveness.
2.PBMSourcesSought_3Year_Final_Sam.Gov.pdf
Jan 28, 2025, 10:11 PM UTC
The Centers for Disease Control and Prevention (CDC) is seeking interested parties to provide Pharmacy Benefits Manager (PBM) services for the World Trade Center (WTC) Health Program, aimed at administering pharmacy benefits for responders and survivors affected by the 9/11 attacks. This contract spans three years with specific implementation and operational timelines, including a transition period, a peak operational phase, and a transition-out phase. The WTC Health Program, established under the Zadroga Act, requires customized drug formularies and prior authorization processes to ensure that only medically necessary treatments are provided in line with the program's regulations. Respondents are expected to demonstrate capabilities in system customization, customer care, clinical services, reporting, and cost control. Challenges in implementation and continuity of care during transitions are acknowledged, with emphasis on the need for innovative solutions and collaboration. Interested vendors must submit their qualifications by February 14, 2025, to support the unique needs of this limited-benefit health program while ensuring compliance and operational efficiency throughout the contract duration.
Lifecycle
Title
Type
CDC WORLD TRADE CENTER (WTC) HEALTH PROGRAM PHARMACY BENEFITS MANAGER
Currently viewing
Sources Sought
Similar Opportunities
World Trade Center Health Program Third-Party Administrator (TPA)
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking a qualified third-party administrator (TPA) for the World Trade Center (WTC) Health Program. The TPA will be responsible for managing enrollment applications, maintaining member information, overseeing a call center, and processing medical claims related to WTC-related health conditions for individuals affected by the September 11th attacks. This program is crucial for providing medical monitoring and treatment to eligible participants, ensuring they receive the necessary care and support. Interested parties should note that the solicitation is anticipated to be released on January 16, 2025, with proposals due by April 11, 2025. For further inquiries, contact Joshua Houston at jhouston@cdc.gov.
World Trade Center Health Program - Outreach and Education
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the World Trade Center (WTC) Health Program's Outreach and Education initiative. The objective is to implement targeted outreach, education, and support services for 9/11 survivors and responders, enhancing awareness and access to health benefits related to their exposure to the September 11 attacks. This program is crucial for addressing the long-term health impacts on approximately 400,000 affected individuals, with current enrollment at only 34%. The solicitation number for this opportunity is 75D30125Q00092, and the contract is expected to span from June 15, 2025, to June 14, 2030, with the potential for multiple awards. Interested parties should contact Joseph Jones at zjb2@cdc.gov for further details and to ensure compliance with submission requirements.
Shared Space and Support Services, San Diego
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source firm fixed price contract to the County of San Diego for shared use of a facility and support services for the US/Mexico Unit and San Diego Quarantine Station. The contract will cover essential services such as installation and maintenance of communication systems, computer support, and building services, which are crucial for facilitating in-person collaboration between CDC staff and the County's Public Health Department. This collaboration is vital to the CDC's mission, with the contract period set from September 1, 2025, to August 31, 2026, and options for two additional one-year extensions. Interested parties should submit their responses to the contract specialist, Taylor Wellman, at xur0@cdc.gov by 5:00 PM (ET) on April 4, 2025.
CDC DFWED NARST Sensititre Supplies
Buyer not available
The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
6505--Perphenazine Tablets (VA-25-00037353)
Buyer not available
The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Perphenazine tablets under solicitation number VA-25-00037353. This contract aims to supply specified quantities of the drug to both the VA and the Department of Defense (DoD) through their Pharmaceutical Prime Vendor (PPV) Programs, with a focus on service-disabled veteran-owned small businesses, women-owned small businesses, and HUBZone small businesses. The procurement is critical for ensuring a consistent supply of pharmaceutical products while adhering to regulatory requirements, including the Drug Supply Chain Security Act (DSCSA) and FDA Good Manufacturing Practices (cGMP). Interested offerors must contact Contract Specialist Anthony DiCrescenzo at Anthony.DiCrescenzo@va.gov for further details, and proposals must include a 0.5% Cost Recovery Fee and a unique National Drug Code (NDC) for each product.
Custom Labels Requirement
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking to procure custom labeling materials through a sole-source contract with Multisystems Inc. This procurement involves specialized RM 66171 Clear PolyPro labels and Thermal Transfer Ribbon Wax/Resin, which are essential for labeling specimen tubes that must endure extremely low temperatures. The labels are critical for the CDC's dengue research specimen handling and must meet specific requirements, including compatibility with the ZT 230 Printer and compliance with CLIA regulations. Interested parties are encouraged to express their capability to fulfill these requirements by April 4, 2025, and should contact Ashley Williams at dal3@cdc.gov or Sheena Delaine at kpz5@cdc.gov for further information.
6505--Aprepitant Capsules
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Aprepitant capsules, a pharmaceutical product essential for various government health facilities, including those under the Department of Defense and Indian Health Service. Offerors are required to provide pricing for multiple line items covering a base year and four option years, adhering to specific conditions such as a 0.5% Cost Recovery Fee and compliance with the Drug Supply Chain Security Act (DSCSA). The contract emphasizes the importance of maintaining current Good Manufacturing Practices (cGMP) and ensuring proper labeling and packaging of the products. Interested contractors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details and must submit their proposals in accordance with the outlined requirements.
Q517--Staffing Service MbM
Buyer not available
The Department of Veterans Affairs is seeking proposals for staffing services under the Meds by Mail (MbM) program, specifically targeting Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). The procurement aims to provide licensed pharmacists and certified pharmacy technicians to support prescription processing at facilities located in Georgia, Wyoming, and Tennessee, with an anticipated increase in workload over the next five years. This contract is crucial for ensuring efficient pharmaceutical services to veterans, with a total contract value of up to $100 million and a minimum guarantee of $2 million across five ordering periods. Interested parties should direct inquiries to Contract Specialist Nicholas L. Schulte at nicholas.schulte1@va.gov, with the proposal submission deadline currently suspended until further notice from the government.
Notice of Intent to Sole Source - Optimoz Inc
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to negotiate a sole source contract with Optimoz Inc. for operations and maintenance support services related to the Virgin Islands’ Immunization Information System (IIS). This procurement aims to enhance the functionality and operational efficiency of IISs, which are critical for assessing vaccination rates and managing public health interventions to prevent vaccine-preventable diseases. The contract is justified under FAR 6.302-1, as Optimoz Inc. is the only vendor capable of providing these services without causing disruption or inefficiency in the existing IIS framework. Interested parties may submit capability statements or proposals to Matthew Nelson at mnelson2@cdc.gov by April 11, 2025, at 4:30 PM EST for consideration.
Notice of Intent to Sole Source - University of Michigan - Vaccine Cost-Effectiveness Models
Buyer not available
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to the University of Michigan for access to proprietary models that assess the cost-effectiveness of vaccines. This procurement aims to secure detailed reports based on these models, which are deemed essential for the CDC's vaccine evaluation efforts, as no other models are known to provide the required level of detail. The contract will cover a base year with four additional option years, and interested parties may express their interest or capability to respond within fifteen days of this notice. Responses should be directed to contract specialists William O’Bryan at rvq0@cdc.gov and Ruben Reyes-Colon at qmz3@cdc.gov by 3:00 PM EDT on April 11, 2025.